The place for remdesivir in COVID-19 treatment

Commentary notes findings from SOLIDARITY trial demand a re-examination of remdesivir, but in the context of other high-quality studies. For now, it is an important COVID-19 treatment option only in selected patient groups.

The Lancet Infectious Diseases